Teladoc Health EPS TDOC
Diluted earnings per share by quarter and over the last twelve months, from 2014.
- Last 12 months, to Jun 30, 2026
- −$0.99
- Latest quarter, Q2 FY26
- −$0.21
- Fiscal year 2025
- −$1.14
Teladoc Health's earnings per share was −$0.99 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.21.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.14 | n/a |
| FY2024 | −$5.88 | n/a |
| FY2023 | −$1.34 | n/a |
| FY2022 | −$84.74 | n/a |
| FY2021 | −$2.77 | n/a |
| FY2020 | −$4.24 | n/a |
| FY2019 | −$1.38 | n/a |
| FY2018 | −$1.48 | n/a |
| FY2017 | −$1.89 | n/a |
| FY2016 | −$1.74 | n/a |
| FY2015 | −$13.83 | n/a |
| FY2014 | −$10.12 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.21 | n/a | −$0.99 | |
| Q1 FY26 | −$0.36 | n/a | −$0.97 | |
| Q4 FY25 | −$0.14 | n/a | −$1.14 | |
| Q3 FY25 | −$0.28 | n/a | −$1.28 | |
| Q2 FY25 | −$0.19 | n/a | −$1.19 | |
| Q1 FY25 | −$0.53 | n/a | −$5.92 | |
| Q4 FY24 | −$0.28 | n/a | −$5.88 | |
| Q3 FY24 | −$0.19 | n/a | −$5.77 | |
| Q2 FY24 | −$4.92 | n/a | −$5.93 | |
| Q1 FY24 | −$0.49 | n/a | −$1.41 | |
| Q4 FY23 | −$0.17 | n/a | −$1.34 | |
| Q3 FY23 | −$0.35 | n/a | −$24.66 |
Against its peers
Companies in Medical - Care Facilities nearest Teladoc Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| TDOCTeladoc Health | −$0.99 | |
| OMDAOmada Health | $0.06 | |
| USPHU S Physical Therapy | $0.88 | −63% a year |
| PNTGPennant | $0.90 | +15% a year |
| ARDTArdent Health | $0.55 | −70% a year |
| HCSGHealthcare Services | $1.72 | +176% a year |
| PGNYProgyny | $0.92 | +56% a year |
| ADUSAddus HomeCare | $5.70 | +26% a year |
| MDPediatrix Medical | $2.09 | +62% a year |
| SBCSBC Medical | $0.47 | +47% a year |
| PRVAPrivia Health | $0.21 | +91% a year |
| Peer median | $0.89 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Teladoc Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.